$ARNA Recent News SP 500 back for another crack at major

New Post Public Reply Private Reply Replies (0) Message Board

Apr 3, 2014 at 10:05 AM

$ARNA Recent News

S&P 500 back for another crack at major support 12:21 p.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 12:41 p.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 1:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 2:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 2:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 7:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 10:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 10:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 7:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 7:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 8:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 1:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 12:07 p.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 8:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 8:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 1:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 2:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 4:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 3:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 10:32 a.m. July 30, 2012 - Val Brickates Kennedy

MNKD: Buy the Rumor, Sell the News 11:37 a.m. April 2, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – ARNA OPK UTHR ALGN 1:15 p.m. April 1, 2014 - InvestorPlace.com
Arena - Scripts, Ads, Sales Reps 12:25 p.m. March 28, 2014 - Seeking Alpha
Direct To Consumer Television Advertising Marks The Tipping Point For Belviq Sales 9:34 a.m. March 24, 2014 - Seeking Alpha
March Madness: Final Four Investing Bracket 2014 6:36 p.m. March 20, 2014 - Seeking Alpha
Arena Down With Overall Market - Sales Data No Help 8:27 a.m. March 17, 2014 - Seeking Alpha
Interesting ARNA Put And Call Options For May 2nd 11:11 a.m. March 13, 2014 - TheStreet.com
Arena Sees Growth Continue With Belviq 4:01 p.m. March 7, 2014 - Seeking Alpha
Have Anti-Obesity Drug Companies Failed? 3:09 p.m. March 7, 2014 - Seeking Alpha
ARNA April 25th Options Begin Trading 11:09 a.m. March 6, 2014 - TheStreet.com
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog 10:58 a.m. March 5, 2014 - Zacks.com
Is A Short Squeeze Ahead for Arena Pharmaceuticals (ARNA)? - Tale of the Tape 9:23 a.m. March 4, 2014 - Zacks.com
10-K: ARENA PHARMACEUTICALS INC 4:52 p.m. March 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
Company news for March 03, 2014 - Corporate Summary 10:06 a.m. March 3, 2014 - Zacks.com
Future Sales Of Arena Pharmaceuticals' BELVIQ: Let's Make Some Informed, Quantitative Predictions Using Expected Value 8:01 a.m. March 3, 2014 - Seeking Alpha
Yellen Comments Help Lift Dow 1.4% on Week 2:03 a.m. March 1, 2014 - Barrons.com
Arena Prescription Sales Up: Stops Stock Slide 5:28 p.m. Feb. 28, 2014 - Seeking Alpha
Arena Posts Wider Loss, Misses Ests - Analyst Blog 12:20 p.m. Feb. 28, 2014 - Zacks.com
Benzinga's Top #PreMarket Losers 7:15 a.m. Feb. 28, 2014 - benzinga.com
Arena's Belviq Sales To Hit $150 Million In 2014? 12:10 a.m. Feb. 28, 2014 - Seeking Alpha

Momentum Indicators for Health Care Equities -- Research on Arena Pharma, Hemispherx Biopharma, PDL BioPharma and Celgene 8:16 a.m. March 20, 2014 - PR Newswire - PRF
Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC 4:30 p.m. March 5, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2013 Financial Results 5:22 p.m. Feb. 27, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Provide Corporate Update and Report Financial Results on Thursday, February 27 9:00 a.m. Feb. 20, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 11:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Announces Filing for Marketing Authorization of BELVIQ® (lorcaserin HCl) in Brazil 9:00 a.m. Feb. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences 9:00 a.m. Feb. 5, 2014 - PR Newswire - PRF
Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena 9:00 a.m. Jan. 9, 2014 - PR Newswire
Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference 9:00 a.m. Jan. 6, 2014 - PR Newswire
Collaborations, FDA Approvals, Appointments, Patents, and Stock Movements - Research Report on Aetna, United Therapeutics, Perrigo, Arena Pharmaceuticals, and Keryx Biopharmaceuticals 9:00 a.m. Dec. 31, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 11:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Insiders Trend Analysis: Tiger Oil and Energy Inc, Groupon Inc, General Motors Company Arena Pharmaceuticals 11:47 a.m. Dec. 19, 2013 - ACCESSWIRE
Opening Buzzers: General Motors Company, Sunedison Inc, Nokia Corporation, Arena Pharmaceuticals 11:11 a.m. Dec. 17, 2013 - ACCESSWIRE
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 9:00 a.m. Dec. 9, 2013 - PR Newswire
Bearish Stocks Analysis: Morgan Stanley, Microsoft Corporation, Arena Pharmaceuticals, Vale SA, JPMorgan Chase & Co 10:17 a.m. Dec. 6, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 10:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Notable News Of The Day: BlackBerry Ltd, Arena Pharmaceuticals, Groupon Inc, Zynga Inc 10:56 a.m. Dec. 2, 2013 - ACCESSWIRE
Promising Partnerships, Stock Price Updates and Participation in Upcoming Healthcare Conferences - Research Report on Quest Diagnostics, Cigna, Arena, Theravance, and Volcano 9:00 a.m. Nov. 29, 2013 - PR Newswire
Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 9:00 a.m. Nov. 27, 2013 - PR Newswire
Trend Analysis Scan: Synovus Financial, Arena Pharmaceuticals, Facebook Inc, J.C. Penney Company, Citigroup 9:49 a.m. Nov. 26, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...